San Diego, CA, United States of America

Albert S Ren

USPTO Granted Patents = 16 

 

 

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 181(Granted Patents)


Company Filing History:


Years Active: 2006-2023

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: Albert S Ren: Innovator in Pharmaceutical Sciences

Introduction

Albert S Ren is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target the 5-HT2C receptor. With a total of 16 patents to his name, Ren's work has the potential to impact various medical conditions.

Latest Patents

Ren's latest patents focus on 5-HT2C receptor agonists and their compositions and methods of use. These inventions relate to compounds that modulate the activity of the 5-HT2C receptor, which is crucial for treating disorders such as obesity, type 2 diabetes, and various psychiatric conditions. The patents detail methods for weight management, inducing satiety, and decreasing food intake, as well as addressing issues like sleep disorders and sexual dysfunction.

Career Highlights

Albert S Ren is currently associated with Arena Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential to provide therapeutic solutions for a range of disorders, including those related to mental health and metabolic conditions.

Collaborations

Ren collaborates with notable colleagues such as Graeme Semple and Yifeng Xiong, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Albert S Ren's contributions to pharmaceutical sciences through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…